Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: Dose-related beneficial versus detrimental effects

Circulation

Volumn 104, Issue 25, 2001, Pages 3125-3131

  Horstick, Georg ^a   Berg, Oliver ^a   Heimann, Axel ^a   Götze, Otto ^b   Loos, Michael ^a   Hafner, Gerd ^a   Bierbach, Benjamin ^a   Petersen, Steffen ^a   Bhakdi, Sucharit ^a   Darius, Harald ^a   Horstick, Marina ^a   Meyer, Jürgen ^a   Kempski, Oliver ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Inhibitors; Ischemia; Myocardial infarction; Myocardium; Reperfusion

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; CREATINE KINASE; SODIUM CHLORIDE; TROPONIN T;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD LEVEL; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL MODEL; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE;

EID: 0035910065     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc5001.100835     Document Type: Article

References (40)

1. The open-artery theory is alive and well - Again
2. Contraction band necrosis and irreversible myocardial injury
3. Decreased myofilament responsiveness in myocardial stunning follows transient calcium overload during ischemia and reperfusion
4. Myocardial oedema: A preventable cause of reperfusion injury?
5. + exchange inhibition in ischemic, reperfused porcine hearts
6. Tissue osmolality, cell swelling, and reperfusion in acute regional myocardial ischemia in the isolated porcine heart
7. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor
8. The relationship of vascular injury and myocardial hemorrhage to necrosis after reperfusion
9. The "no-reflow"phenomenon after temporary coronary occlusion in the dog
10. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction
11. Cytokines and the microcirculation in ischemia and reperfusion
12. Resident cardiac mast cells degranulate and release preformed TNF-αinitiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion
13. Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion
14. Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion
15. Rescue therapy with C1-esterase inhibitor concentrate after emergency coronary surgery for failed PTCA
16. Schwerwiegende thrombenbildung nach berinert HS
17. Capillary leak syndrome after open heart surgery for congenital heart defects: Therapy with C1-inhibitor
18. Surgical procedure affects physiological parameters in rat myocardial ischemia: Need for mechanical ventilation
19. Production and characterisation of peptide-specific monoclonal antibodies that recognise a neoepitope on hog C5a
20. Biotinylation of proteins via amino groups can induce binding to U937 cells, HL-60 cells, monocytes and granulocytes
21. Fluorescent microspheres to measure organ perfusion: Validation of a simplified sample processing technique
22. Potentiation of C1 inhibitor by glycosaminoglycans: Dextran sulfate species are effective inhibitors of in vitro complement activation in plasma
23. The regulation of human factor XIIa by plasma proteinase inhibitors
24. C1 inhibitor: The predominant inhibitor of plasma kallikrein
25. 2+
26. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients: Further evidence for the role of the contact system in fibrinolysis in vivo
27. Inactivation of kallikrein in human plasma
28. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma
29. Activation of plasminogen by human plasma kallikrein
30. High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: A novel mechanism for contact activation
31. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation
32. Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, are selective inhibitors of α-thrombin-induced platelet activation
33. Tissue plasminogen activator release in vivo in response to vasoactive agents
34. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
35. Consecutive enzyme cascades: Complement activation at the cell surface triggers increased tissue factor activity
36. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury
37. Chronic heart failure induced by coronary artery ligation in Lewis inbred rats
38. Species variation in the coronary collateral circulation during regional myocardial ischaemia: A critical determinant of the rate of evolution and extent of myocardial infarction
39. Effect of early coronary artery reperfusion on infarct development in a model of low collateral flow
40. Loss of canine myocardial nicotinamide adenine dinucleotides determines the transition from reversible to irreversible ischemic damage of myocardial cells